These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6439109)

  • 1. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enhanced effectiveness of antibiotic therapy with an exogenous lysozyme in dysentery in children].
    Vereshchagin IA; Vereshchagin SI; Zhuravleva OD
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):927-31. PubMed ID: 3936408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery].
    Boĭko IN; Khavinson VKh; Morozov VG
    Voen Med Zh; 1985 Jul; (7):45-6. PubMed ID: 3901509
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of determining the spectrum of blood serum fatty acids in evaluating increasing the effectiveness of antibiotic therapy of dysentery in children with prodigiozan and ephedrine].
    Vereshchagin IA; Zhuravleva OD
    Antibiot Khimioter; 1989 Mar; 34(3):218-23. PubMed ID: 2502081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of dysentery and the specific alteration of the neutrophils in children in the use of monomycin and a diet with an increased protein content].
    Vereshchagin IA; Chernichenko AM
    Antibiotiki; 1979 Jul; 24(7):532-5. PubMed ID: 380456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Free amino acid content in the blood and urine from the use of monomycin on children with dysentery].
    Vereshchagin IA
    Antibiotiki; 1976 Aug; 21(8):754-8. PubMed ID: 793513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulating effect of prodigiozan on nonspecific reactivity in typhoid fever, dysentery and staphylococcal infection].
    Kuz'min VG; Loban KM; Medvedeva MM
    Antibiotiki; 1978 Mar; 23(3):264-8. PubMed ID: 345961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased effectiveness of antibiotic therapy with adaptogens in dysentery and Proteus infection in children].
    Vereshchagin IA; Geskina OD; Bukhteeva ER
    Antibiotiki; 1982 Jan; 27(1):65-9. PubMed ID: 7036851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prodigiosin in the overall therapy of dysentery and in the prevention of intrahospital viral respiratory infection in children].
    Zlatkovskaia NM; Kleĭmenova IS; Evdoshenko VG; Zelenaia SN; Fuger NM
    Antibiotiki; 1975 Apr; 20(4):365-9. PubMed ID: 1108774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic therapy of acute dysentery in children with immunologic deficiency conditions].
    Vereshchagin IA; Zhuravleva OD
    Antibiot Khimioter; 1991 Jan; 36(1):38-41. PubMed ID: 2053823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of tablet forms of monomycin in children with acute dysentery].
    Vershchagin IA; Ivanova SS; Bukhteeva ER; Mukhina LI; Golosnaia RD
    Antibiotiki; 1977 Nov; 22(11):1028-31. PubMed ID: 339824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the effectiveness of antibacterial preparations in treating dysentery].
    Suptel' EA; Zagornaia NB; Bass TM
    Antibiotiki; 1979 Mar; 24(3):207-10. PubMed ID: 156002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analysis of the effect of polymyxin and monomycin on dysentery bacteria and enteropathogenic Coli bacteria in experiments and clinical cases].
    Khodalevich IV
    Antibiotiki; 1972 Mar; 17(3):222-4. PubMed ID: 4337880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of comprehensive antibacterial therapy in combination with prodigiozan on energy metabolic indices in children and adolescents with pulmonary tuberculosis].
    Kshanovs'kyĭ SA; Rushchak VA; Maliuk VI; Vel'tman RV; Polner RA
    Pediatr Akus Ginekol; 1979; (3):16-8. PubMed ID: 379787
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of prodigiozan in the overall therapy of dysentery in children].
    Sosnova MA; Zelenaia SN
    Zdravookhr Kirg; 1976; (6):19-21. PubMed ID: 13573
    [No Abstract]   [Full Text] [Related]  

  • 16. [The characteristics of the antibiotic therapy of acute dysentery in an immunodeficiency body state in children with leukopenia].
    Vereshchagin IA; Zhuravleva OD
    Lik Sprava; 1994 Jan; (1):103-7. PubMed ID: 8067000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral vaccination using live, apathogenic nondependent Shigella organisms].
    Meitert T; Istrati G; Ciufecu C; Sulea IT
    Z Gesamte Hyg; 1972 Oct; 18(10):753-6. PubMed ID: 4581672
    [No Abstract]   [Full Text] [Related]  

  • 18. [State of immunogenesis in different methods of treating acute dysentery].
    Chernaia TT; Beĭsembaev EA
    Klin Med (Mosk); 1980 Feb; 58(2):31-4. PubMed ID: 6988643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative effectiveness of the treatment of acute dysentery].
    Lyskovtsev MM; Myshkina OK; Romanova IG; Levicheva VS
    Klin Med (Mosk); 1979 Aug; 57(8):74-7. PubMed ID: 388065
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of prodigiozan in the overall treatment of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushchak VA; Tsymbaliuk GF; Kostromina VP; Medvedeva MM
    Probl Tuberk; 1980 Jan; (1):33-6. PubMed ID: 6966060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.